Condition
Anxious Depression
Total Trials
4
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 4 (3)
Trial Status
Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05632497Recruiting
Alteration of Symbiosis Intestinal Microbiota on Patients With Anorexia Nervosa
NCT06004115Phase 4Recruiting
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
NCT04245748Phase 4RecruitingPrimary
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
NCT02544607Phase 4Completed
Ketamine for Depression: An MRI Study
Showing all 4 trials